Literature DB >> 18784812

Nodular lymphocyte-predominant hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas.

Frank X Zhao1.   

Abstract

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare indolent B-cell lymphoma. However, its morphology can resemble T-cell/histiocyte rich large B-cell lymphoma (T/HRBCL), a subtype of more aggressive diffuse large B-cell lymphoma. More and more studies suggest that these two entities are closely related. In this report, a 59-year-old man with nodal NLPHL and concomitant T/HRBCL in the bone marrow is presented, the current progress in our understanding of these two closely related B-cell lymphomas reviewed and the problems in the diagnosis and differentiation of NLPHL and T/HRBCL discussed.

Entities:  

Keywords:  Nodular lymphocyte-predominant Hodgkin lymphoma; T-cell/histiocyte rich large B-cell lymphoma; “grey zone” lymphoma

Year:  2008        PMID： 18784812      PMCID： PMC2480562     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN： 1936-2625


  25 in total

1.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.

Authors:  E Torlakovic; A Tierens; H D Dang; J Delabie
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Non-mediastinal grey zone lymphomas and report from the workshop.

Authors:  Harald Stein; Korinna Jöhrens; Ioannis Anagnostopoulos
Journal:  Eur J Haematol Suppl       Date:  2005-07

3.  Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.

Authors:  S Alkan; C W Ross; C A Hanson; B Schnitzer
Journal:  Mod Pathol       Date:  1995-06       Impact factor: 7.842

4.  Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy?

Authors:  J T Sundeen; J Cossman; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1988-08       Impact factor: 6.394

5.  Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.

Authors:  V Diehl; M Sextro; J Franklin; M L Hansmann; N Harris; E Jaffe; S Poppema; M Harris; K Franssila; J van Krieken; T Marafioti; I Anagnostopoulos; H Stein
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

6.  Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.

Authors:  Ludmila Boudová; Emina Torlakovic; Jan Delabie; Peter Reimer; Beate Pfistner; Sabine Wiedenmann; Volker Diehl; Hans-Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

Review 7.  Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).

Authors:  T Rüdiger; E S Jaffe; G Delsol; C deWolf-Peeters; R D Gascoyne; A Georgii; N L Harris; M E Kadin; K A MacLennan; S Poppema; H Stein; L E Weiss; H K Müller-Hermelink
Journal:  Ann Oncol       Date:  1998       Impact factor: 32.976

8.  Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage.

Authors:  R S Wickert; D D Weisenburger; A Tierens; T C Greiner; W C Chan
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

9.  Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma.

Authors:  Iwona Wlodarska; Peet Nooyen; Brigitte Maes; José I Martin-Subero; Reiner Siebert; Patrick Pauwels; Chris De Wolf-Peeters; Anne Hagemeijer
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

10.  Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.

Authors:  T Wang; J Lasota; C A Hanau; M Miettinen
Journal:  APMIS       Date:  1995-09       Impact factor: 3.205
View more
  5 in total

1.  Large B-cell lymphoma with an unusual infiltrating pattern: report of two cases.

Authors:  Neil G Haycocks; X Frank Zhao
Journal:  Int J Clin Exp Pathol       Date:  2010-10-11

Review 2.  Pitfalls in diagnostic hematopathology -- Part II.

Authors:  Xianfeng F Zhao
Journal:  Int J Clin Exp Pathol       Date:  2009-09-10

3.  Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies.

Authors:  Diponkar Banerjee
Journal:  Adv Hematol       Date:  2011-01-18

Review 4.  Second malignancies in Hodgkin's disease: A review of the literature and report of a case with a secondary Lennert's lymphoma.

Authors:  Ernst Jg Norval; Erich J Raubenheimer
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

5.  A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide.

Authors:  Mamatha Siricilla; Lydia Irwin; Andres Ferber
Journal:  Case Rep Oncol Med       Date:  2018-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.